Kang, Y James (2011) Copper and homocysteine in cardiovascular diseases. Pharmacol Ther 129:321-31
|
Xie, Huiqi; Kang, Y James (2009) Role of copper in angiogenesis and its medicinal implications. Curr Med Chem 16:1304-14
|
Feng, Wenke; Ye, Fei; Xue, Wanli et al. (2009) Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 75:174-82
|
Purohit, Vishnudutt; Bode, J Christian; Bode, Christiane et al. (2008) Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42:349-61
|
Zhou, Yang; Jiang, Youchun; Kang, Y James (2008) Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 45:106-17
|
Kang, Y James; Jiang, Youchun; Saari, Jack T (2007) Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart. J Nutr Biochem 18:714-8
|
Lynes, Michael A; Kang, Y James; Sensi, Stefano L et al. (2007) Heavy metal ions in normal physiology, toxic stress, and cytoprotection. Ann N Y Acad Sci 1113:159-72
|
Feng, Wenke; Wang, Yuehui; Cai, Lu et al. (2007) Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions. Biochem Biophys Res Commun 360:286-9
|
Kang, Y James (2007) Antioxidant defense against anthracycline cardiotoxicity by metallothionein. Cardiovasc Toxicol 7:95-100
|
Merten, Kevyn E; Jiang, Youchun; Kang, Y James (2007) Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells. Exp Biol Med (Maywood) 232:682-9
|
Showing the most recent 10 out of 52 publications